Arkolith/Insider Trading/SLDB/Form 4

Ganot Ilan

DirectorSolid Biosciences Inc. (SLDB) · full profile →Form 4 · filed Jan 30, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1K
Net Open-Market Flow
-$1K
Transactions
5
3 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 28, 2026Sell(S)191$6.59$1K17K
Jan 27, 2026Option exercise(M)4K——99K
Jan 27, 2026Option exercise(M)389——18K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 27, 2026Option exercise(M)389—$00
Jan 27, 2026Option exercise(M)4K—$00

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-031765) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML